Amphastar Pharmaceuticals (AMPH) Cash from Operations Growth (1y) (2014 - 2026)
Amphastar Pharmaceuticals (AMPH) Cash from Operations Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn | 81.06% |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn | 8.26% |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn | -46.22% |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | 63.59% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 73.78% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 33.73% |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn | 16.88% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 944.46 Mn | 654.33 Mn | 93.47 Mn | 44.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 44.20% |
| Mar 31, 2026 | 36.39% |
| Dec 31, 2025 | 13.23% |
| Sep 30, 2025 | -12.31% |
| Jun 30, 2025 | -48.50% |
| Mar 31, 2025 | -36.56% |
| Dec 31, 2024 | 21.62% |
| Sep 30, 2024 | -6.80% |
| Jun 30, 2024 | 25.83% |
| Mar 31, 2024 | 36.92% |
| Dec 31, 2023 | 56.73% |
| Sep 30, 2023 | 215.75% |
| Jun 30, 2023 | 1,851.08% |
| Mar 31, 2023 | -20.45% |
| Dec 31, 2022 | -62.35% |
| Sep 30, 2022 | 693.11% |
| Jun 30, 2022 | -91.25% |
| Mar 31, 2022 | 122.41% |
| Dec 31, 2021 | 139.40% |
| Sep 30, 2021 | -70.83% |